Agavins Impact on Gastrointestinal Tolerability-Related Symptoms during a Five-Week Dose-Escalation Intervention in Lean and Obese Mexican Adults: Exploratory Randomized Clinical Trial

Agavins are prebiotics and functional fiber that modulated the gut microbiota and metabolic status in obese mice. Here, we designed a placebo-controlled, double-blind, exploratory study to assess fluctuations in gastrointestinal (GI) tolerability-related symptoms to increasing doses of agavins in 38...

Full description

Bibliographic Details
Main Authors: María Blanca Silva-Adame, Arlen Martínez-Alvarado, Víctor Armando Martínez-Silva, Virginia Samaniego-Méndez, Mercedes G. López
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Foods
Subjects:
Online Access:https://www.mdpi.com/2304-8158/11/5/670
_version_ 1797475131581267968
author María Blanca Silva-Adame
Arlen Martínez-Alvarado
Víctor Armando Martínez-Silva
Virginia Samaniego-Méndez
Mercedes G. López
author_facet María Blanca Silva-Adame
Arlen Martínez-Alvarado
Víctor Armando Martínez-Silva
Virginia Samaniego-Méndez
Mercedes G. López
author_sort María Blanca Silva-Adame
collection DOAJ
description Agavins are prebiotics and functional fiber that modulated the gut microbiota and metabolic status in obese mice. Here, we designed a placebo-controlled, double-blind, exploratory study to assess fluctuations in gastrointestinal (GI) tolerability-related symptoms to increasing doses of agavins in 38 lean and obese Mexican adults for five weeks and their impact on subjective appetite, satiety, metabolic markers, and body composition. All GI symptoms showed higher scores than placebo at almost every dose for both lean and obese groups. Flatulence caused an intense discomfort in the lean-agavins group at 7 g/day, while obese-agavins reported a mild-to-moderate effect for all five symptoms: no significant differences among 7, 10, and 12 g/day for flatulence, bloating, and diarrhea. Ratings for any GI symptom differed between 10 and 12 g/day in neither group. The inter-group comparison demonstrated a steady trend in GI symptoms scores in obese participants not seen for lean volunteers that could improve their adherence to larger trials. Only body weight after 10 g/day reduced from baseline conditions in obese-agavins, with changes in triglycerides and very-low-density lipoproteins compared to placebo at 5 g/day, and in total cholesterol for 10 g/day. Altogether, these results would help design future trials to evaluate agavins impact on obese adults.
first_indexed 2024-03-09T20:39:49Z
format Article
id doaj.art-5ec9ef0af27449a6b57e82eff268c82b
institution Directory Open Access Journal
issn 2304-8158
language English
last_indexed 2024-03-09T20:39:49Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Foods
spelling doaj.art-5ec9ef0af27449a6b57e82eff268c82b2023-11-23T23:00:41ZengMDPI AGFoods2304-81582022-02-0111567010.3390/foods11050670Agavins Impact on Gastrointestinal Tolerability-Related Symptoms during a Five-Week Dose-Escalation Intervention in Lean and Obese Mexican Adults: Exploratory Randomized Clinical TrialMaría Blanca Silva-Adame0Arlen Martínez-Alvarado1Víctor Armando Martínez-Silva2Virginia Samaniego-Méndez3Mercedes G. López4Departamento de Biotecnología y Bioquímica, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Unidad Irapuato, Guanajuato 36824, MexicoCentro de Estudios Cardiometabólicos S.C., Mexico City 07760, MexicoCentro de Estudios Cardiometabólicos S.C., Mexico City 07760, MexicoCentro de Estudios Cardiometabólicos S.C., Mexico City 07760, MexicoDepartamento de Biotecnología y Bioquímica, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Unidad Irapuato, Guanajuato 36824, MexicoAgavins are prebiotics and functional fiber that modulated the gut microbiota and metabolic status in obese mice. Here, we designed a placebo-controlled, double-blind, exploratory study to assess fluctuations in gastrointestinal (GI) tolerability-related symptoms to increasing doses of agavins in 38 lean and obese Mexican adults for five weeks and their impact on subjective appetite, satiety, metabolic markers, and body composition. All GI symptoms showed higher scores than placebo at almost every dose for both lean and obese groups. Flatulence caused an intense discomfort in the lean-agavins group at 7 g/day, while obese-agavins reported a mild-to-moderate effect for all five symptoms: no significant differences among 7, 10, and 12 g/day for flatulence, bloating, and diarrhea. Ratings for any GI symptom differed between 10 and 12 g/day in neither group. The inter-group comparison demonstrated a steady trend in GI symptoms scores in obese participants not seen for lean volunteers that could improve their adherence to larger trials. Only body weight after 10 g/day reduced from baseline conditions in obese-agavins, with changes in triglycerides and very-low-density lipoproteins compared to placebo at 5 g/day, and in total cholesterol for 10 g/day. Altogether, these results would help design future trials to evaluate agavins impact on obese adults.https://www.mdpi.com/2304-8158/11/5/670agavinsfunctional fiberGI tolerabilityobesitybranched neo-fructans
spellingShingle María Blanca Silva-Adame
Arlen Martínez-Alvarado
Víctor Armando Martínez-Silva
Virginia Samaniego-Méndez
Mercedes G. López
Agavins Impact on Gastrointestinal Tolerability-Related Symptoms during a Five-Week Dose-Escalation Intervention in Lean and Obese Mexican Adults: Exploratory Randomized Clinical Trial
Foods
agavins
functional fiber
GI tolerability
obesity
branched neo-fructans
title Agavins Impact on Gastrointestinal Tolerability-Related Symptoms during a Five-Week Dose-Escalation Intervention in Lean and Obese Mexican Adults: Exploratory Randomized Clinical Trial
title_full Agavins Impact on Gastrointestinal Tolerability-Related Symptoms during a Five-Week Dose-Escalation Intervention in Lean and Obese Mexican Adults: Exploratory Randomized Clinical Trial
title_fullStr Agavins Impact on Gastrointestinal Tolerability-Related Symptoms during a Five-Week Dose-Escalation Intervention in Lean and Obese Mexican Adults: Exploratory Randomized Clinical Trial
title_full_unstemmed Agavins Impact on Gastrointestinal Tolerability-Related Symptoms during a Five-Week Dose-Escalation Intervention in Lean and Obese Mexican Adults: Exploratory Randomized Clinical Trial
title_short Agavins Impact on Gastrointestinal Tolerability-Related Symptoms during a Five-Week Dose-Escalation Intervention in Lean and Obese Mexican Adults: Exploratory Randomized Clinical Trial
title_sort agavins impact on gastrointestinal tolerability related symptoms during a five week dose escalation intervention in lean and obese mexican adults exploratory randomized clinical trial
topic agavins
functional fiber
GI tolerability
obesity
branched neo-fructans
url https://www.mdpi.com/2304-8158/11/5/670
work_keys_str_mv AT mariablancasilvaadame agavinsimpactongastrointestinaltolerabilityrelatedsymptomsduringafiveweekdoseescalationinterventioninleanandobesemexicanadultsexploratoryrandomizedclinicaltrial
AT arlenmartinezalvarado agavinsimpactongastrointestinaltolerabilityrelatedsymptomsduringafiveweekdoseescalationinterventioninleanandobesemexicanadultsexploratoryrandomizedclinicaltrial
AT victorarmandomartinezsilva agavinsimpactongastrointestinaltolerabilityrelatedsymptomsduringafiveweekdoseescalationinterventioninleanandobesemexicanadultsexploratoryrandomizedclinicaltrial
AT virginiasamaniegomendez agavinsimpactongastrointestinaltolerabilityrelatedsymptomsduringafiveweekdoseescalationinterventioninleanandobesemexicanadultsexploratoryrandomizedclinicaltrial
AT mercedesglopez agavinsimpactongastrointestinaltolerabilityrelatedsymptomsduringafiveweekdoseescalationinterventioninleanandobesemexicanadultsexploratoryrandomizedclinicaltrial